Found: 10
Select item for more details and to access through your institution.
Front & Back Matter.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 1, doi. 10.1159/000526655
- Publication type:
- Article
The Clinical Tumor Lysis Syndrome in a Patient with Mixed Phenotype Acute Leukemia Undergoing Induction with Venetoclax and Azacitidine: A Case Report.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 173, doi. 10.1159/000524182
- By:
- Publication type:
- Article
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 142, doi. 10.1159/000524077
- By:
- Publication type:
- Article
Novel Tetrazoles against Acanthamoeba castellanii Belonging to the T4 Genotype.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 183, doi. 10.1159/000520585
- By:
- Publication type:
- Article
Efficacy and Safety of Super-Selective Bronchial Arterial Infusion Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 123, doi. 10.1159/000522456
- By:
- Publication type:
- Article
Body Mass Index of Elderly Patients with Normal Renal Function as a Determining Factor for Initial Vancomycin Regimen Designing.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 193, doi. 10.1159/000522455
- By:
- Publication type:
- Article
New Frontiers in the Medical Therapy of Hepatocellular Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 164, doi. 10.1159/000521837
- By:
- Publication type:
- Article
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 152, doi. 10.1159/000521741
- By:
- Publication type:
- Article
Quercetin Inhibits Glioblastoma Growth and Prolongs Survival Rate through Inhibiting Glycolytic Metabolism.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 132, doi. 10.1159/000523905
- By:
- Publication type:
- Article
Venetoclax in Combination with Hypomethylating Agents for the Treatment of Treatment-Naive B/Myeloid Mixed-Phenotype Acute Leukemia and Relapsed/Refractory Acute Myeloid Leukemia: A Report of 3 Cases.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 178, doi. 10.1159/000519882
- By:
- Publication type:
- Article